Neurofit SAS
Offers a wide range of neuroscience preclinical services including in vivo and in vitro validated tests.
Launch date
Employees
Illkirch Grand Est (HQ)
Financials
Estimates*
| EUR | 2015 | 2020 | 2021 |
|---|---|---|---|
| Revenues | 2.2m | <1m | 1.6m |
| % growth | - | - | 103 % |
| EBITDA | <1m | (<1m) | (<1m) |
| % EBITDA margin | 1 % | (16 %) | (6 %) |
| Profit | <1m | (<1m) | <1m |
| % profit margin | 18 % | (10 %) | 3 % |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Acquisition | |
| Total Funding | - | ||
Recent News about Neurofit SAS
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.